Using neuroeconomics to study psychiatry

July 19, 2012

Neuroeconomics experts and guest editors of the Biological Psychiatry special issue Carla Sharp, John Monterosso, and P. Read Montague in an introductory paper define neuroeconomics as "an interdisciplinary field that brings together psychology, economics, neuroscience, and computational science to investigate how people make decisions."

is a relatively new field that traditionally has studied the decision-making process of healthy individuals. It does so by using in conjunction with behavioral economic experiments. For example, an experiment may involve a gambling task where individuals must repeatedly choose between two options, one considered risky and one safe. The corresponding occurring during each choice is recorded and analyzed, allowing researchers to study and understand the underlying processes of those decisions.

In healthy individuals, investigators study optimal decision-making strategies. However, in psychiatric populations, studying alterations in decision-making can provide insights into the neurobiology underlying "real world" functional impairments. Dr. Sharp commented that "neuroeconomics provides an interdisciplinary platform for researchers to study reward-related decision-making as it relates to psychiatric disorder across multiple levels of explanation." Thus, in this introductory paper to the special issue, the authors detail the reasons why neuroeconomics is a useful approach to study psychiatric behavior.

Abnormal decision-making has been identified in many psychiatric disorders, including substance abuse and addiction disorders, depression, anxiety, and attention-deficit/hyperactivity disorder. Individuals with these disorders tend to respond differently to rewards and losses, which includes how much value they place on immediate versus delayed rewards, and even how choices are altered based on the potential size of the reward. Neuroeconomics can be used to study these differential patterns of decision-making, which theoretically, could later be used to develop improved treatments.

Neuroeconomics may also advance psychiatry in a larger way by promoting the development of a new classification system based on linking pathology in brain systems to behavioral disturbances. This is a lofty and important goal for psychiatry, highlighted by the National Institute of Mental Health Strategic Plan that identifies the need for "new ways of classifying mental disorders based on dimensions of observable behavior and neurobiological measures". This would move the field beyond the categorical classification system that has been used for decades to diagnose and study .

"Neuroeconomics is one of the hottest areas in cognitive neuroscience. We are extremely pleased to have leaders in this field discuss its important implications for psychiatry," said John Krystal, Editor of .

For now, the authors note that the "application of neuroeconomics to psychopathology has only just begun," but the papers in this special issue detail how and why this field can and should move forward.

Explore further: The neuroscience of choosing: Can we understand how the brain makes decisions?

More information: "Neuroeconomics: A Bridge for Translational Research" by Carla Sharp, John Monterosso, and P. Read Montague (doi: 10.1016/j.biopsych.2012.02.029). The article appears in Biological Psychiatry, Volume 72, Issue 2 (July 15, 2012)

Related Stories

The neuroscience of choosing: Can we understand how the brain makes decisions?

September 15, 2011
Although still a young field, research in "decision neuroscience" has exploded in the last decade, with scientists beginning to decipher what exactly is happening in our brains when we are making choices, whether big or small.

Recommended for you

Many kinds of happiness promote better health, study finds

July 21, 2017
A new study links the capacity to feel a variety of upbeat emotions to better health.

Study examines effects of stopping psychiatric medication

July 20, 2017
Despite numerous obstacles and severe withdrawal effects, long-term users of psychiatric drugs can stop taking them if they choose, and mental health care professionals could be more helpful to such individuals, according ...

Study finds gene variant increases risk for depression

July 20, 2017
A University of Central Florida study has found that a gene variant, thought to be carried by nearly 25 percent of the population, increases the odds of developing depression.

In making decisions, are you an ant or a grasshopper?

July 20, 2017
In one of Aesop's famous fables, we are introduced to the grasshopper and the ant, whose decisions about how to spend their time affect their lives and future. The jovial grasshopper has a blast all summer singing and playing, ...

Perceiving oneself as less physically active than peers is linked to a shorter lifespan

July 20, 2017
Would you say that you are physically more active, less active, or about equally active as other people your age?

Old antibiotic could form new depression treatment

July 19, 2017
An antibiotic used mostly to treat acne has been found to improve the quality of life for people with major depression, in a world-first clinical trial conducted at Deakin University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.